Promoter Methylation-Regulated miR-148a-3p Inhibits Lung Adenocarcinoma (LUAD) Progression by Targeting MAP3K9

Investigators demonstrated that mitogen-activated protein (MAP) kinase kinase kinase 9 (MAP3K9) was the target of miR-148a-3p and that MAP3K9 levels were significantly increased in both lung adenocarcinoma cell lines and clinical tumor tissues.